Quality Payment Program Measures Data |
Back to Merit-based Incentive Payment System |
| Measure ID | NQF ID | National Quality Strategy Domain | Title | High Priority | Measure Type | Submission Methods | Speciality Measure Sets | |
|---|---|---|---|---|---|---|---|---|
| HCPR4 | Efficiency and Cost Reduction | Mean Length of Stay for Inpatients – CHF | Outcome | Registry | Details | |||
| HCPR5 | Efficiency and Cost Reduction | Mean Length of Stay for Inpatients – COPD | Outcome | Registry | Details | |||
| HCPR3 | Efficiency and Cost Reduction | Mean Length of Stay for Inpatients – Pneumonia | Outcome | Registry | Details | |||
| ABFM9 | Communication and Care Coordination | Measuring the Value-Functions of Primary Care: Provider Level Continuity Measure | Structure | Registry | Details | |||
| 444 | Efficiency and Cost Reduction | Medication Management for People with Asthma | Process | Registry | Family Medicine | Internal Medicine | Pediatrics | Details | ||
| AAN5 | Effective Clinical Care | Medication Prescribed For Acute Migraine Attack | Process | Registry | Details | |||
| 397 | Communication and Care Coordination | Melanoma Reporting | Process | Claims | Registry | Pathology | Details | ||
| AAD12 | Patient Safety | Melanoma: – Appropriate Surgical Margins | Intermediate Outcome | Registry | Details | |||
| 137 | Communication and Care Coordination | Melanoma: Continuity of Care - Recall System | Structure | Registry | Dermatology | Details | ||
| 138 | Communication and Care Coordination | Melanoma: Coordination of Care | Process | Registry | Dermatology | Details | ||
| CAP18 | Communication and Care Coordination | Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Primary or Metastatic Colorectal Carcinoma | Process | Registry | Details | |||
| QOPI25 | Patient Safety | Moderate Hypofractionization for Prostate Cancer | Process | Registry | Details | |||
| 477 | Effective Clinical Care | Multimodal Pain Management | Process | Registry | Anesthesiology | Details | ||
| ACRAD34 | Patient Safety | Multi-strata weighted average for 3 CT Exam Types: Overall Percent of CT exams for which Dose Length Product is at or below the size-specific diagnostic reference level (for CT Abdomen-pelvis with contrast/single phase scan, CT Chest without contrast/single phase scan and CT Head/Brain without contrast/single phase scan) | Outcome | Registry | Details | |||
| IGR4 | Efficiency and Cost Reduction | Myocardial Perfusion Imaging (MPI) studies or Stress Echocardiography imaging studies not Equivocal | Efficiency | Registry | Details | |||
| IGR5 | Effective Clinical Care | Myocardial Perfusion Imaging (MPI) studies, Transthoracic Echo (TTE), or Stress Echocardiography imaging studies reporting Left Ventricular Ejection Fraction | Process | Registry | Details | |||
| IGR11 | Efficiency and Cost Reduction | Myocardial Perfusion Imaging (MPI), Transthoracic Echocardiography (TTE), or Stress Echocardiography studies meeting appropriate use criteria | Efficiency | Registry | Details | |||
| USWR23 | Effective Clinical Care | Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential | Process | Registry | Details | |||
| AQUA18 | Effective Clinical Care | Non-Muscle Invasive Bladder Cancer: Early surveillance cystoscopy within 4 months of initial diagnosis | Process | Registry | Details | |||
| AQUA17 | Effective Clinical Care | Non-Muscle Invasive Bladder Cancer: Initiation of BCG within 3 months of diagnosis of high-grade T1 bladder cancer and/or CIS | Process | Registry | Details |